Session 5- When Haematopoiesis goes wrong Flashcards
myeloproliferative neoplasms
a group of diseases of the
bone marrow in which excess cells are produced. They arise from
genetic mutations in the precursors of the myeloid lineage in the
bone marrow.
what are the 4 types of MPN
- Polycythaemia vera (excess erythrocytes)
- Essential thrombocythaemia (overproduction of
megakaryocytes leading to excess platelets) - Primary myelofibrosis (initial proliferative phase followed by
replacement of haematopoietic tissue by connective tissue
leading to impairment of the generation of all blood cells
(pancytopenia)) - Chronic myeloid leukaemia (excess granulocytes)
what is polycythaemia
s a disease state in which the volume percent of
erythrocytes in the blood (the haematocrit) exceeds 52% (males) or
48% (females). This situation can arise from either an increase in the
number erythrocytes (termed absolute polycythaemia) or to a
decrease in the plasma volume (termed relative polycythaemia).
relative polycythaemia
decrease in plasma volume
absolute polycythaemia
increase in number of erythrocytes
primary polycythaemia
abnormaility originates in bone marrow
What causes secondary polycythaemia
caused by increased levels of erythropoeitin
- physiological response to hypoxia - high altitude, chronic lung disease
- abnormal production- renal carcinoma, renal artery stenosis
polycythemia vera
specific form of polycythaemia which
arises from a myeloproliferative neoplasm in the bone marrow
resulting in overproduction of erythrocytes
caused by mutation of the gene coding for Janus Kinase 2 (JAK2)
clinical features associated with polycythaemia
- Thrombosis (venous & arterial)
- Haemorrhage (skin or GI tract)
- Headache and ‘dizziness’
- Plethora
- Burning pain in the hands or feet (Erythromelalgia)
- Pruritus
- Splenic discomfort, splenomegaly
- Gout
- Arthritis
- May transform to myelofibrosis or acute leukaemia
treatment of polycythaemia vera
phlebotomy
aspirin
cytoreduction agents- hydroxycarbamide
thrombocytosis
increase in the platelet count compared to the normal range of a person of the same gender and age. Thrombocytosis is a common reaction to infection and inflammation and is seen often in hospitalised patients
essential thrombocythaemia
thrombocytosis as a result
of a myeloproliferative neoplasm- a rare chronic blood cancer characterised by the overproduction of platelets by megakaryocytes in bone marrow
common symptoms of essential thrombocythaemia
• Numbness in the extremities
• Thrombosis (most often arterial e.g. stroke or peripheral
gangrene)
• Disturbances in hearing and vision (related to microvascular
complications)
• Headaches
• Burning pain in the hands or feet (Erythromelalgia)
thrombocytopenia
abnormally low level of platelets
symptoms of acquired thrombocytopenia
bleeding gums
nosebleeds
heavier or longer menstrual periods.
petechiae (small red/purple spots on the skin) are usually seen
on the feet, shins and forearms.
causes of acquired thrombocytopenia
a decrease in platelet production, increased consumption of platelets (e.g. due to DIC) or an increased destruction of platelets
treatment of acquired thrombocytopenia
depends on the specific cause of the disease and focuses
on eliminating the underlying problem (e.g. discontinuing a drug or
treating underlying sepsis
immune thrombocytopenic purpura (ITP)
an autoimmune disease characterised by isolated
thrombocytopenia which can take an acute (short-lived) or chronic
course
primary myelofibrosis
a myeloproliferative neoplasm where the
proliferation of mutated hematopoietic stem cells results in reactive
bone marrow fibrosis eventually leading to the replacement of
marrow with scar tissue (collagen deposition).
symptoms of myelofibrosis
- Hepatosplenomegaly
- Bruising
- Fatigue (and other symptoms related to anaemia)
- Weight loss
- Fever
- Increased sweating
- Portal hypertension
treatment of myeolofibrosis
Hydroxycarbamide, folic
acid, and allopurinol may have some benefits and patients with
advance disease may require blood transfusions and sometimes
splenectomy.
recently ruxolitnib
chronic myeloid leukaemia
unregulated growth of
myeloid cells in the bone marrow leading to the accumulation of
mature granulocytes (mainly neutrophils) as well as myelocytes in
blood
aplastic anemia
a rare disease resulting in damage to bone
marrow and hematopoietic stem cells
leading to pancytopenia (a deficiency of all
three blood cell types: red blood cells
(anaemia), white blood cells (leucopenia),
and platelets (thrombocytopenia)
aplastic
inability of the
stem cells to generate mature blood cells